Skip to main content
OpenTrials
Completed

NCT Number: NCT03707210

Virtual Reality Application in Chemotherapy

The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in the VR program and ISO document.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chemotherapy Training

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Taipei Medical University

Taipei County, Taiwan

About this study

As technology advances, mobile devices have gradually turned into wearable devices. Furthermore, virtual reality (VR), augmented reality (AR), and mixed reality (MR) are being increasingly applied in medical fields such as medical education and training, surgical simulation, neurological rehabilitation, psychotherapy, and telemedicine. Research results demonstrate the ability of VR, AR, and MR to ameliorate the inconveniences that are often associated with traditional medical care, reduce incidents of medical malpractice caused by unskilled operations, and reduce the cost of medical education and training. What is more, the application of these technologies has enhanced the effectiveness of medical education and training, raised the level of diagnosis and treatment, improved the doctor-patient relationship, and boosted the efficiency of medical execution. The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in VR program and ISO document.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The staffs who require to implement chemotherapy skill in the hospital.
  • Age over 20 years.

Exclusion criteria

  • Refuse to join the study.

Treatment and study plan

VR training program

Behavioral

Use VR software to make a training education program.

Primary outcomes

  1. The questionnaire about intervention effect

    Time frame: After intervention 1 week, to perform the test. Including the content design, the convenience, the effectiveness, and promotion.

    After intervention, the investigator want to know the effect of intervention. A total of 12 questions, using the Likert's scale, very disagree(1) to very agree(5). It will compute a total score, score high means more effective.

Secondary outcomes

  1. The questionnaire of Knowledge level for chemotherapy technique

    Time frame: Before the intervention, the investigator perform a pretest. After intervention 1 week, the investigator perform the post test.

    The questionnaire want to understand the Knowledge for chemotherapy operation skill before and after intervention. A total of ten questions, with scores ranging from 0 to 10 points. , score high means more correct.

  2. The questionnaire of Attitude for chemotherapy operation

    Time frame: Before the intervention, the investigator perform a pretest. After intervention 1 week, the investigator perform the post test.

    The questionnaire want to understand the Attitude for chemotherapy operation skill before and after intervention. A total of ten questions, using the likert's scale, very disagree with 1 point, very agree with 5 points, total scores between 10 points and 50 points. , score high means more active.

Sponsors and collaborators

Lead sponsor

Taipei Medical University

Other

Collaborators

  • Taipei Medical University WanFang Hospital

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Oct 16, 2018
Registry last updated
May 28, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.